apo-terbinafine terbinafine 250mg (as hydrochloride) tablet blister pack
arrotex pharmaceuticals pty ltd - terbinafine hydrochloride, quantity: 281.3 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: methylcellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica - apo-terbinafine is indicated for: treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infections caused by dermatophytes such as trichophyton (e.g. t. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.
terbinafine teva 250 mg
teva israel ltd - terbinafine as hydrochloride - caplets - terbinafine as hydrochloride 250 mg - terbinafine - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral terbinafine should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral terbinafine is not effective against vaginal candidiasis or pityriasis (tinea) versicolor.onychomycoses ( tinea unguium, ringworm of the nails) due to infection with dermatophyte organisms ( hyphomycetes).
terbinafine-250 tablet
pro doc limitee - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines
terbinafine tablet
cobalt pharmaceuticals company - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines
terbinafine tablet
sanis health inc - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines
q-terbinafine tablet
qd pharmaceuticals ulc - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines
terbinafine tablet
sivem pharmaceuticals ulc - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines
terbinafine- terbinafine tablet
harris pharmaceutical, inc. - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine 250 mg - terbinafine tablets, usp are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (koh) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets, usp are contraindicated in individuals with a history of allergic reaction to oral terbinafine because of the risk of anaphylaxis. pregnancy category b there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response and because treatment of onychomycosis can be postponed until after pregnancy is completed, it is recommended that terbinafine tablets not be initiated during pregnancy. oral reproduction studies have been performed in rabbits and rats at doses up to 300 mg/kg/day [12x to 23x the maximum recommended human dose (mrhd), in rabbits and rats, respe
terbinafine-asteria cream for external use
hankook korus pharm co. - terbinafine (terbinafine hydrochloride) - cream for external use - 10mg/g
nu-terbinafine tablet
nu-pharm inc - terbinafine (terbinafine hydrochloride) - tablet - 250mg - terbinafine (terbinafine hydrochloride) 250mg - allylamines